MBX Biosciences (MBX) Appoints Steve Hoerter to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to MBX Biosciences (MBX) Appoints Steve Hoerter to its Board

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

April 7, 2025 8:00 AM EDT

CARMEL, Ind., April 07, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the appointment of Steve Hoerter as an independent director to the Companys Board of Directors. Mr. Hoerter brings over three decades of pharmaceutical commercialization and executive leadership experience as well as a proven track record of building and growing life science companies.

I am thrilled to welcome Steve Hoerter to the Companys Board as an... More